The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
This Study in Healthy Men and Women Tests How the Body Takes up BI 409306
- Status
- COMPLETED
- Phase
- PHASE1
Digital Auscultation Test - IPF Data Collection
- Status
- COMPLETED
- Phase
- PHASE4
Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).
- Status
- COMPLETED
- Phase
- PHASE4
This Study in Healthy Men Tests How the Body Takes up BI 1467335
- Status
- COMPLETED
- Phase
- PHASE1
This Study in Healthy Volunteers Determines the Amount of BI 730460 in the Blood When Taken as Tablet. It Looks at How Different Doses of BI 730460 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How Food Influences the Amount of BI 730460 in the Blood.
- Status
- TERMINATED
- Phase
- PHASE1
BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Contrast Nephropathy in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- N/A
A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Empa PASS on Urinary Tract Malignancies
- Status
- COMPLETED
- Phase
- N/A
Detection of Early Idiopathic Pulmonary Fibrosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors)
- Status
- COMPLETED
- Phase
- PHASE1
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms
- Status
- COMPLETED
- Phase
- PHASE3
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.
- Status
- COMPLETED
- Phase
- PHASE3
This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM
- Status
- COMPLETED
- Phase
- PHASE3
Effects of Dual Bronchodilator Treatment on Cardiopulmonary Interactions in COPD
- Status
- COMPLETED
- Phase
- PHASE4
This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.
- Status
- COMPLETED
- Phase
- PHASE1
Greek NIS Spiolto ELLACTO
- Status
- COMPLETED
- Phase
- N/A